| scholarly article | Q13442814 |
| P50 | author | Guido von Figura | Q63133710 |
| Akihisa Fukuda | Q96232982 | ||
| P2093 | author name string | David W Dawson | |
| Jorge Ferrer | |||
| Matthias Hebrok | |||
| Klemens J Hertel | |||
| William F Mueller | |||
| Matthew A Firpo | |||
| Sean J Mulvihill | |||
| Holger A Russ | |||
| Anke Busch | |||
| Grace E Kim | |||
| Nilotpal Roy | |||
| Muluye E Liku | |||
| John P Morris Iv | |||
| P2860 | cites work | Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas | Q24299520 |
| The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors | Q24304941 | ||
| Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma | Q24337664 | ||
| Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes | Q24595981 | ||
| Core signaling pathways in human pancreatic cancers revealed by global genomic analyses | Q24606006 | ||
| Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma | Q24609544 | ||
| ARID1A mutations in endometriosis-associated ovarian carcinomas | Q24610484 | ||
| Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer | Q24633517 | ||
| TopHat: discovering splice junctions with RNA-Seq | Q24655505 | ||
| The human genome browser at UCSC | Q24672361 | ||
| The Sequence Alignment/Map format and SAMtools | Q27860966 | ||
| Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer | Q28277002 | ||
| Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer | Q28277781 | ||
| Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice | Q28586163 | ||
| Cells of origin in cancer | Q29619557 | ||
| Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse | Q29620396 | ||
| Epigenetics and cancer without genomic instability. | Q33346513 | ||
| Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice | Q33604913 | ||
| Epithelial tissues have varying degrees of susceptibility to Kras(G12D)-initiated tumorigenesis in a mouse model | Q33818230 | ||
| KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. | Q33858490 | ||
| Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas | Q34100230 | ||
| Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse | Q34596182 | ||
| Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma | Q34642090 | ||
| Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. | Q34786695 | ||
| Suppression of lung adenocarcinoma progression by Nkx2-1 | Q34939788 | ||
| Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development | Q35178284 | ||
| ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers | Q35501591 | ||
| BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI. | Q35545332 | ||
| Cystic precursors to invasive pancreatic cancer | Q35609914 | ||
| Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. | Q35619635 | ||
| Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways | Q35641254 | ||
| Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas | Q36221363 | ||
| Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression. | Q36426956 | ||
| Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration | Q36570146 | ||
| SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells | Q36573136 | ||
| SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus | Q36710858 | ||
| Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice | Q36999854 | ||
| Roles of HMGA proteins in cancer | Q37001370 | ||
| LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest | Q37165210 | ||
| Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes | Q37249683 | ||
| SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity | Q37262178 | ||
| Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts | Q37483711 | ||
| Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder | Q37730596 | ||
| SWI/SNF nucleosome remodellers and cancer. | Q37886668 | ||
| Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation | Q39156056 | ||
| Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas | Q39469747 | ||
| STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. | Q39540918 | ||
| Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit | Q40066403 | ||
| Role for BRG1 in cell cycle control and tumor suppression | Q40376914 | ||
| Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma | Q41856856 | ||
| Pancreatic exocrine duct cells give rise to insulin-producing beta cells during embryogenesis but not after birth | Q43199149 | ||
| Stabilization of beta-catenin impacts pancreas growth. | Q46218922 | ||
| Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm | Q46307212 | ||
| Targeted knockout of BRG1 potentiates lung cancer development | Q46593349 | ||
| Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. | Q53329413 | ||
| Expression of METH-1 and METH-2 in pancreatic cancer. | Q54501923 | ||
| Expression of p270(ARID1A), a component of human SWI/SNF complexes, in human tumors | Q58199286 | ||
| Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer | Q60594558 | ||
| Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5 | Q78570048 | ||
| HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma | Q83323078 | ||
| Intraductal papillary mucinous neoplasm | Q84582374 | ||
| P433 | issue | 3 | |
| P921 | main subject | Intraductal papillary mucinous neoplasm | Q17149811 |
| adenocarcinoma | Q356033 | ||
| invasive ductal carcinoma | Q1671685 | ||
| mucinous tumor | Q6931145 | ||
| pancreatic ductal carcinoma | Q8263002 | ||
| pancreatic ductal adenocarcinoma | Q18555956 | ||
| P304 | page(s) | 255-267 | |
| P577 | publication date | 2014-02-23 | |
| P1433 | published in | Nature Cell Biology | Q1574111 |
| P1476 | title | The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma | |
| P478 | volume | 16 |
| Q30669159 | A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics |
| Q38459854 | Acinar cell reprogramming: a clinically important target in pancreatic disease |
| Q93017993 | Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication |
| Q28074465 | Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications |
| Q55713410 | Arid1a restrains Kras-dependent changes in acinar cell identity. |
| Q46862467 | Atypical flat lesions derive from pancreatic acinar cells |
| Q96430967 | BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice |
| Q90640062 | BRG1 attenuates colonic inflammation and tumorigenesis through autophagy-dependent oxidative stress sequestration |
| Q33898452 | BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness |
| Q57754503 | Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis |
| Q35228755 | Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation |
| Q90566625 | Carcinogenesis of Pancreatic Ductal Adenocarcinoma |
| Q39161835 | Cells of origin of pancreatic neoplasms |
| Q63866039 | Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer |
| Q26774942 | Developmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular Origin |
| Q39384816 | Differentiation and Inflammation: 'Best Enemies' in Gastrointestinal Carcinogenesis |
| Q33635144 | Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm |
| Q47111525 | Duct- and Acinar-Derived Pancreatic Ductal Adenocarcinomas Show Distinct Tumor Progression and Marker Expression. |
| Q90139280 | Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma |
| Q36295189 | Dynamic recruitment of functionally distinct Swi/Snf chromatin remodeling complexes modulates Pdx1 activity in islet β cells |
| Q41931284 | ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation |
| Q57179338 | Epigenetics of gastrointestinal diseases: notes from a workshop |
| Q47121552 | Epithelial-Myeloid cell crosstalk regulates acinar cell plasticity and pancreatic remodeling in mice. |
| Q96614781 | Exosomes: A Potential Therapeutic Tool Targeting Communications between Tumor Cells and Macrophages |
| Q38906990 | Exploiting receptor tyrosine kinase co-activation for cancer therapy |
| Q26781848 | GEMMs as preclinical models for testing pancreatic cancer therapies |
| Q39013082 | GLI1, a master regulator of the hallmark of pancreatic cancer |
| Q26765438 | Genetics and biology of pancreatic ductal adenocarcinoma |
| Q46867228 | Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts |
| Q90185432 | HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer |
| Q38951185 | Impact of Pdx1-associated chromatin modifiers on islet β-cells |
| Q41070965 | Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer |
| Q38786245 | KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis |
| Q38909404 | Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality. |
| Q37650946 | Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer |
| Q41175540 | Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS. |
| Q47259787 | Loss of PTEN and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice |
| Q36576557 | Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type |
| Q57287731 | MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1 |
| Q39441268 | Molecular Events in the Natural History of Pancreatic Cancer |
| Q38370174 | Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer |
| Q38434627 | Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma |
| Q89242498 | Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism |
| Q38683437 | Neat1 is a p53-inducible lincRNA essential for transformation suppression |
| Q89531796 | Oncogene-dependent function of BRG1 in hepatocarcinogenesis |
| Q34456438 | Organoid models of human and mouse ductal pancreatic cancer |
| Q52579471 | Overexpression of HER2 in the pancreas promotes development of intraductal papillary mucinous neoplasms in mice. |
| Q37587988 | PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance |
| Q28079735 | Pancreatic Cancer, A Mis-interpreter of the Epigenetic Language |
| Q92435020 | Pancreatic and duodenal homeobox-1 in pancreatic ductal adenocarcinoma and diabetes mellitus |
| Q57423198 | Pancreatic cancer |
| Q26747524 | Pancreatic cancer from bench to bedside: molecular pathways and treatment options |
| Q57755850 | Pancreatic cancer: spotlight on BRG1 |
| Q39204274 | Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts. |
| Q41737306 | Plasticity and dedifferentiation within the pancreas: development, homeostasis, and disease |
| Q91713425 | Promoter-Level Transcriptome Identifies Stemness Associated With Relatively High Proliferation in Pancreatic Cancer Cells |
| Q99551711 | RNF43 Mutations in IPMN Cases: A Potential Prognostic Factor |
| Q30841369 | Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells |
| Q28086849 | Regulation of Cellular Identity in Cancer |
| Q89151862 | Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer |
| Q35204997 | Reprogramming of human cancer cells to pluripotency for models of cancer progression |
| Q57753119 | SCF-mediated degradation of Brg1 suppresses gastric cancer metastasis |
| Q26998657 | SWI/SNF chromatin remodeling complexes and cancer |
| Q57471060 | SWI/SNF component restrains pancreatic neoplasia formation |
| Q64890448 | Signaling Networks That Control Cellular Plasticity in Pancreatic Tumorigenesis, Progression, and Metastasis. |
| Q91622915 | Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma |
| Q41463557 | Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer. |
| Q50640303 | The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer |
| Q56967209 | The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis |
| Q65002383 | The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male Mice. |
| Q93081350 | The Use of Genetically Engineered Mouse Models for Studying the Function of Mutated Driver Genes in Pancreatic Cancer |
| Q35954277 | The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma |
| Q37699177 | The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A. |
| Q36712626 | The cis-regulatory switchboard of pancreatic ductal cancer |
| Q98196633 | The role of histone methylation in the development of digestive cancers: a potential direction for cancer management |
| Q34089949 | Whole genome expression profiling shows that BRG1 transcriptionally regulates UV inducible genes and other novel targets in human cells |
| Q38817859 | p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells. |
Search more.